Supporting the

Neuroendocrine Cancer Community

Getting a better deal for people with rare and less common cancers

Jul 23, 2019

With nearly half of new diagnoses, and over half of cancer deaths being from rare or less common cancers, improving care and support for people with rare and less common cancers cannot be ignored.

In 2018 over 670 people with a rare or less common cancer shared their experiences with Cancer52 in the hope that changes can be made in the future.

“We hope sharing this insight from people with rare and less common cancers will help us and all who work with us to improve diagnosis, treatment and care for all those with rare and less common cancers” Jane Lyons, Cancer52 CEO

[npfButton size=“small” text=”Find out more” href=”https://docs.wixstatic.com/ugd/e22361_4144e7d1f36846388198be6f33f244b7.pdf” background-colour=”#f06124″ text-colour=”#ffffff”]